VerImmune Revenue and Competitors

Location

$10M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • VerImmune's estimated annual revenue is currently $852.5k per year.(i)
  • VerImmune's estimated revenue per employee is $65,577
  • VerImmune's total funding is $10M.

Employee Data

  • VerImmune has 13 Employees.(i)
  • VerImmune grew their employee count by 30% last year.

VerImmune's People

NameTitleEmail/Phone
1
Founding CEO & PresidentReveal Email/Phone
2
Head CMCReveal Email/Phone
3
Head CMCReveal Email/Phone
4
Associate Scientist I (Preclinical process development)Reveal Email/Phone
5
Scientist, Non-clinicalReveal Email/Phone
6
Executive Business AdvisorReveal Email/Phone
7
Senior Research AssociateReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.4M3934%N/AN/A
#2
$1.2M6-14%N/AN/A
#3
$13.6M10242%N/AN/A
#4
$1.1M740%N/AN/A
#5
$0.9M1330%$10MN/A
#6
$5.1M3115%N/AN/A
#7
$132.5M7649%N/AN/A
#8
N/A4300%N/AN/A
#9
$0.9M740%N/AN/A
#10
$0.6M30%N/AN/A
Add Company

What Is VerImmune?

VerImmune is advancing Anti-tumor Immune Redirection (AIR): A Breakthrough Therapy that Redirects Pre-Existing Immune Memory from Childhood Vaccination or Infection to Fight Cancer

keywords:N/A

$10M

Total Funding

13

Number of Employees

$852.5k

Revenue (est)

30%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.1M1363%$16.2M
#2
$0.5M13-7%$3M
#3
$3.5M13N/AN/A
#4
$1M1318%N/A
#5
$2.4M13-19%N/A